The Center for Drug Evaluation and Research (CDER) is tasked with tracking, reporting, and maintaining records related to drug and biological product applications. These records are used for reporting to Congress on various performance goals under the Prescription Drug User Fee Act (PDUFA), Biosimilar User Fee Act (BSUFA), and other regulations. CDER’s previous tracking and archiving systems were outdated, leading to the creation of the Document Archiving, Reporting, and Regulatory Tracking System (DARRTS), a multi-tier, web-based enterprise application designed to streamline application submissions, document archiving, and report generation.